🇺🇸 FDA
Pipeline program

filgrastim

CDR0000067665

Phase 3 mab active

Quick answer

filgrastim for Lymphoma is a Phase 3 program (mab) at Solid Biosciences with 2 ClinicalTrials.gov record(s).

Program details

Company
Solid Biosciences
Indication
Lymphoma
Phase
Phase 3
Modality
mab
Status
active

Clinical trials